Joanna Olszak

Joanna Olszak

Auto-generated profile, based on publicly available information

Joanna Olszak

Warszawski Uniwersytet Medyczny

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2025 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
KZKarolina Zalewa
Karolina Zalewa
JOJoanna Olszak
Joanna Olszak
WKWojciech Kapłan
Wojciech Kapłan
DODominika Orłowska
Dominika Orłowska
LBLidia Bartoszek
Lidia Bartoszek
NKNatalia Klepacz
Natalia Klepacz
Introduction and purposeArtificial intelligence (AI), particularly machine learning (ML) and deep learning (DL), is revolutionizing radiology by improving diagnostic accuracy and efficiency. This paper examines AI applications, especially convolutional neural networks (CNNs), in diagnosing pulmonary diseases, such as pneumonia, tuberculosis, and lung cancer. The goal is to explore the impact of these technologies and assess challenges in their integration into clinical practice. Material and methodsThis review is based on articles from the PubMed database, published between 2015 and 2024, using keywords such as artificial intelligence in radiology, AI in medicine, AI in chest X-ray, and AI in chest-CT. ResultsAI, driven by ML and DL, has significantly enhanced medical imaging analysis, automating tasks that require expert interpretation. CNNs excel in processing raw image data and identifying hierarchical features, surpassing traditional methods in diagnosing lung diseases from radiographs and CT scans. AI systems demonstrate exceptional accuracy in detecting pneumonia, tuberculosis, and lung cancer, providing rapid, consistent results, particularly valuable in resource-limited settings. However, challenges persist, including the need for diverse training datasets, model interpretability, and integration into existing workflows. ConclusionsAI, especially CNN-based DL models, is reshaping radiology by advancing diagnostic capabilities. While it often outperforms traditional methods, AI is best used to complement human expertise. Overcoming challenges in data quality, system integration, and training is essential for broader clinical adoption. Continued research will enhance AI’s reliability and utility, ultimately improving patient outcomes.

30 January 2024 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
DODominika Orłowska
Dominika Orłowska
WKWojciech Kapłan
Wojciech Kapłan
JOJan Ostański
Jan Ostański
KZKarolina Zalewa
Karolina Zalewa
LBLidia Bartoszek
Lidia Bartoszek
JOJoanna Olszak
Joanna Olszak
Introduction and Purpose Hyperosmolar Hyperglycemic State (HHS), a severe type 2 diabetes complication, presents with profound hyperglycemia, hyperosmolality, and dehydration sans ketosis, posing distinct challenges in diagnosis and treatment compared to diabetic ketoacidosis (DKA). This article aims to enhance medical community awareness by examining HHS features, prevalence, and associated risk factors, contributing to improved clinical management. Emphasizing tailored treatment strategies for dehydration, coexisting illnesses, and metabolic decompensation, it ultimately seeks to enhance outcomes for type 2 diabetes individuals. Material and methods Conducting a systematic review of medical articles from 1972 to 2023 using PubMed, this study analyzed keywords such as hyperglycemic hyperosmolar state, HHS, diabetes mellitus, hyperglycemia, and dehydration. Inclusion of pertinent articles ensured a comprehensive exploration of Hyperosmolar Hyperglycemic State (HHS) literature during the specified timeframe. Brief description of the state of knowledge. Hyperosmolar Hyperglycemic Syndrome (HHS) predominantly affects elderly type 2 diabetes individuals, often triggered by infections like pneumonia or urinary tract infections. Clinical presentation includes fatigue, weakness, polydipsia, polyuria, nausea, and altered consciousness. Diagnosis relies on criteria such as elevated blood glucose levels and increased osmolality. HHS management involves a multidisciplinary approach, addressing fluid depletion, compromised cerebral perfusion, and achieving gradual normalization of osmolality and blood glucose levels to prevent complications. Summary Hyperosmolar Hyperglycemic Syndrome (HHS), a severe metabolic disorder linked to diabetes, extends beyond hyperglycemia, necessitating a comprehensive understanding. This review sheds light on HHS etiology, clinical manifestations, diagnostic criteria, and treatment modalities, emphasizing its critical nature in diabetes care.

17 May 2025 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
JOJoanna Olszak
Joanna Olszak
KZKarolina Zalewa
Karolina Zalewa
RBRafał Budzyński
Rafał Budzyński
AKAnna Kamieniak
Anna Kamieniak
NKNatalia Klepacz
Natalia Klepacz
MKMarta Kaus
Marta Kaus
Introduction and Purpose: Cerebral palsy (CP) is a complex motor and postural disorder resulting from damage to the developing brain. The causes of CP are diverse and can occur at various stages of a child’s life— prenatal, perinatal, and postnatal. The aim of this paper is to review the scientific literature on the causes of CP, with a particular focus on the mechanisms of brain damage at each stage. Material and methods: A comprehensive literaturere view was conducted using the PubMed database, focusing on articles published until the end of 2024. The search included the keywords:"cerebral palsy","etiology","brain damage"and "prevention" in various combinations. Relevant studies were selected based on criteria such as etiology of cerebral palsy. Results: Analysis of available studies indicates that prenatal causes predominantly include genetic abnormalities, intrauterine infections, and exposure to toxins. Perinatal causes involve asphyxia, mechanical trauma, and prematurity. In the postnatal period, infections of the nervous system, traumatic brain injuries, and perinatal complications play a significant role. These causes are often interdependent, highlighting the necessity of a comprehensive approach to CP risk analysis. Conclusion: Understanding the multifactorial etiology of CP is essential for developing effective prevention strategies. Further research into the mechanisms of brain damage may contribute to reducing the incidence of new cases and improving the quality of life for children with CP.

9 May 2023 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
WKWojciech Kapłan
Wojciech Kapłan
KZKarolina Zalewa
Karolina Zalewa
DRDominika Rachwał
Dominika Rachwał
LBLidia Bartoszek
Lidia Bartoszek
JOJoanna Olszak
Joanna Olszak
EPEwa Piątek
Ewa Piątek
Introduction: Worldwide, cannabis is the most widely used illegal psychoactive substance and the third most common drug, after alcohol and tobacco. Cannabis use disorder (CUD) affects approximately 10% of the 193 million cannabis users worldwide. In recent years, cannabinoids have become more and more popular. The CUD is becoming a growing social and health problem. The search for effective forms of pharmacotherapy is still ongoing, and an effective combination of psychotherapy and pharmacotherapy may be crucial for the future of CUD treatment. Material and method: The article was based on a review and analysis of publications and discoveries in recent years, which were available in the PubMed and Google Scholar database. Results: 82 study participants attempted abstinence from cannabis use. In the final primary endpoint analysis, both 400 mg of CBD and 800 mg of CBD were more effective than placebo in reducing cannabis use. 50 people who were addicted to cannabis treated with gabapentin showed a significant reduction in cannabis use and cannabis withdrawal compared to placebo. Moreover, 70 men addicted to cannabis were randomized and those, who used FAAH inhibitors reported fewer cannabis withdrawal symptoms, less cannabis use and lower THC urine levels than placebo users. Conclusions: Gabapentin has been proven to show a reduction in CUD. The use of CBD, FAAH inhibitors and psychotherapy MET/CBT/CM also appear to be effective. In addition, the use of the principles of People-First Language, avoiding slang and idioms, using medical and curing vocabulary, respects the addicted person, and also positively influences the chances of abstinence.

4 August 2024 in Quality in Sport
Verified
Journal Article
Open access
PDF file
DODominika Orłowska
Dominika Orłowska
JOJoanna Olszak
Joanna Olszak
KZKarolina Zalewa
Karolina Zalewa
LBLidia Bartoszek
Lidia Bartoszek
WKWojciech Kapłan
Wojciech Kapłan
JSJakub Starownik
Jakub Starownik
Introduction and PurposeThe gut microbiome is crucial to infant health and development. For premature infants, microbiome development differs from full-term babies, posing long-term health risks. Factors such as delivery method, feeding, antibiotic treatment, and neonatal intensive care unit (NICU) environment significantly influence the microbiome of premature infants. Probiotics, especially Bifidobacterium strains, show promise in enhancing health and reducing risks of necrotizing enterocolitis (NEC) and late-onset sepsis (LOS).Material and MethodsThis review is based on articles from the PubMed database, covering the years 2004-2023, using keywords: gut microbiome, premature infants, probiotic, microbiome development, and neonatal intensive care unit.ResultsCurrent research indicates probiotics, particularly Bifidobacterium strains, positively impact the gut microbiome of premature infants, improving immunity and metabolism, and providing protection against NEC and LOS. Multi-strain probiotic preparations combining Bifidobacterium and Lactobacilaceae strains appear promising, but further research is needed to fully understand their effects. Addressing food intolerance (FI) in premature infants is another potential application of microbiome-focused therapies.ConclusionsWhile probiotics show promise in improving the microbiome of preterm infants, comprehensive research on single and multi-strain probiotics and their specific mechanisms of action is needed. Controversies persist regarding the safety, FDA regulation, and selection of specific probiotics and formulations. There is no consensus on the optimal timing for introducing probiotics. Further research is required to optimize probiotic selection and determine the best benefits. Enhanced standardization and oversight are essential to ensure safe and effective use of probiotics in neonatal healthcare.

4 December 2024 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
JOJoanna Olszak
Joanna Olszak
KZKarolina Zalewa
Karolina Zalewa
LBLidia Bartoszek
Lidia Bartoszek
DODominika Orłowska
Dominika Orłowska
WKWojciech Kapłan
Wojciech Kapłan
AMAlicja Milewska
Alicja Milewska
Introduction and Purpose Phantom limb pain (PLP) is a complex and multifactorial phenomenon that arises following limb amputation, affecting a significant number of patients. This study aims to explore the underlying mechanisms of PLP, assess current treatment strategies, and evaluate the effectiveness of various therapeutic interventions, including pharmacological and non-pharmacological approaches. Material and Methods A comprehensive literature review was conducted using the PubMed database, focusing on articles published up to the end of 2023. The search included the keywords: "amputation", "mirror therapy", "pain", "phantom limb", "amputation-induced pain", "chronic pain" in various combinations. Relevant studies were selected based on criteria such as the etiopathogenesis of phantom pain and its treatment methods. Results The findings indicate that PLP is associated with both peripheral and central nervous system changes, influenced by individual risk factors such as genetics and psychological state. Therapeutic interventions such as mirror therapy, graded motor imagery, and neuromodulation have shown promise in alleviating symptoms, although the evidence for their effectiveness remains variable. The implementation of a multidisciplinary approach significantly improves outcomes in managing PLP. Conclusions Effective management of phantom limb pain requires a comprehensive understanding of its etiology and a tailored treatment strategy that incorporates both pharmacological and non-pharmacological methods. Future research should focus on establishing robust clinical protocols and long-term efficacy studies to enhance the quality of life for individuals suffering from PLP.